STOCK TITAN

Anheuser Busch Financials

BUD
Source SEC Filings (10-K/10-Q) Data as of Dec 31, 2025 Currency USD FYE December

This page shows Anheuser Busch (BUD) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BUD FY2025

Flat sales are still producing rising cash because lower reinvestment needs and steady deleveraging are doing the heavy lifting.

Over the recent annual run, free cash flow rose from $8.6B to $11.2B even though sales were essentially flat. Because capex also stepped down over that span, the earnings lift looks tied to better cash conversion and lower reinvestment drag, not simple volume growth.

The balance sheet is being reshaped by internal cash: debt to equity improved from 1.4x to 0.7x while financing cash flow remained negative. That means the business has been paying down claims on itself even while returning $2.6B through buybacks and $4.5B through dividends.

More than half of total assets are goodwill at $117.9B, versus equity of $97.7B, which signals an acquisition-built balance sheet rather than one backed mainly by physical assets. With a current ratio of 0.7x, the practical support for creditors and owners is ongoing cash generation, not a large pool of liquid or tangible assets.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 29 / 100
Financial Health Score 29/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Anheuser Busch's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth
31

Anheuser Busch's revenue declined 0.7% year-over-year, from $59.8B to $59.3B. This contraction results in a growth score of 31/100.

Leverage
52

Anheuser Busch has a moderate D/E ratio of 0.75. This balance of debt and equity financing earns a leverage score of 52/100.

Liquidity
9

Anheuser Busch's current ratio of 0.72 is below the typical benchmark, resulting in a score of 9/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
84

Anheuser Busch converts 18.9% of revenue into free cash flow ($11.2B). This strong cash generation earns a score of 84/100.

Piotroski F-Score Partial
6/8

Anheuser Busch passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed
1.76x

For every $1 of reported earnings, Anheuser Busch generates $1.76 in operating cash flow ($14.9B OCF vs $8.5B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$59.3B
YoY-0.7%
5Y CAGR+4.8%
10Y CAGR+3.3%

Anheuser Busch generated $59.3B in revenue in fiscal year 2025. This represents a decrease of 0.7% from the prior year.

EBITDA
N/A
Net Income
$8.5B
YoY+14.3%
5Y CAGR+30.9%
10Y CAGR-1.5%

Anheuser Busch reported $8.5B in net income in fiscal year 2025. This represents an increase of 14.3% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
$11.2B
YoY+0.3%
5Y CAGR+9.6%
10Y CAGR+1.8%

Anheuser Busch generated $11.2B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 0.3% from the prior year.

Cash & Debt
$11.6B
YoY+4.2%
5Y CAGR-5.3%

Anheuser Busch held $11.6B in cash against $73.0B in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
1.80B
YoY+0.0%
5Y CAGR+1.2%

Anheuser Busch had 1.80B shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
14.3%
YoY+1.9pp
5Y CAGR+9.6pp
10Y CAGR-8.6pp

Anheuser Busch's net profit margin was 14.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.9 percentage points from the prior year.

Return on Equity
8.7%
YoY+0.3pp
5Y CAGR+5.9pp
10Y CAGR-12.9pp

Anheuser Busch's ROE was 8.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.3 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
$2.6B
YoY+188.9%

Anheuser Busch spent $2.6B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 188.9% from the prior year.

Capital Expenditures
$3.7B
YoY-5.4%
5Y CAGR-0.7%
10Y CAGR-2.6%

Anheuser Busch invested $3.7B in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 5.4% from the prior year.

BUD Income Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

BUD Balance Sheet

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Total Assets $218.8B+3.6% $211.1B+2.2% $206.6B-1.9% $210.7B-3.9% $219.3B+1.4% $216.4B+1.6% $212.9B+0.3% $212.4B
Current Assets $24.8B+16.8% $21.2B-7.8% $23.0B+9.4% $21.0B-10.0% $23.4B+8.8% $21.5B-7.3% $23.2B+11.9% $20.7B
Cash & Equivalents $11.6B+62.4% $7.2B-35.9% $11.2B+51.2% $7.4B-28.5% $10.3B+50.9% $6.8B-31.3% $10.0B+41.9% $7.0B
Inventory $5.1B-6.7% $5.5B+9.1% $5.0B-9.8% $5.6B-0.3% $5.6B-18.4% $6.8B+3.4% $6.6B+8.3% $6.1B
Accounts Receivable $6.2B-11.9% $7.0B+32.7% $5.3B-21.4% $6.7B+11.3% $6.0B-8.9% $6.6B+24.0% $5.3B-9.1% $5.9B
Goodwill $117.9B+2.7% $114.8B+3.9% $110.5B-2.6% $113.5B-3.1% $117.0B+0.8% $116.2B+2.8% $113.0B-2.1% $115.4B
Total Liabilities $121.1B+1.2% $119.7B+1.5% $117.9B-2.9% $121.5B-4.1% $126.7B-0.7% $127.6B-0.9% $128.7B-0.8% $129.6B
Current Liabilities $34.5B+4.4% $33.0B-0.2% $33.1B+8.2% $30.6B-17.7% $37.2B+10.0% $33.8B-1.8% $34.4B+11.3% $30.9B
Long-Term Debt $73.0B N/A $72.2B N/A N/A N/A N/A N/A
Total Equity $97.7B+6.9% $91.4B+3.1% $88.7B-0.6% $89.2B-3.7% $92.7B+4.4% $88.8B+5.3% $84.3B+1.8% $82.8B
Retained Earnings $50.1B+5.2% $47.6B+2.3% $46.6B+7.0% $43.5B+3.1% $42.2B+7.5% $39.3B+1.1% $38.8B+12.7% $34.4B

BUD Cash Flow Statement

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Operating Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Capital Expenditures N/A N/A N/A N/A N/A N/A N/A N/A
Free Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Investing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Financing Cash Flow N/A N/A N/A N/A N/A N/A N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

BUD Financial Ratios

Metric Q4'25 Q2'25 Q4'24 Q2'24 Q4'23 Q2'23 Q4'22 Q2'22
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 0.72+0.1 0.64-0.1 0.700.0 0.69+0.1 0.630.0 0.64-0.0 0.670.0 0.67
Debt-to-Equity 0.75-0.6 1.31+0.5 0.81-0.5 1.360.0 1.37-0.1 1.44-0.1 1.53-0.0 1.57
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: The current ratio is below 1.0 (0.72), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Frequently Asked Questions

Anheuser Busch (BUD) reported $59.3B in total revenue for fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Anheuser Busch (BUD) revenue declined by 0.7% year-over-year, from $59.8B to $59.3B in fiscal year 2025.

Yes, Anheuser Busch (BUD) reported a net income of $8.5B in fiscal year 2025, with a net profit margin of 14.3%.

As of fiscal year 2025, Anheuser Busch (BUD) had $11.6B in cash and equivalents against $73.0B in long-term debt.

Anheuser Busch (BUD) had a net profit margin of 14.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Anheuser Busch (BUD) has a return on equity of 8.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Anheuser Busch (BUD) generated $11.2B in free cash flow during fiscal year 2025. This represents a 0.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Anheuser Busch (BUD) generated $14.9B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Anheuser Busch (BUD) had $218.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Anheuser Busch (BUD) invested $3.7B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Anheuser Busch (BUD) spent $2.6B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Anheuser Busch (BUD) had 1.80B shares outstanding as of fiscal year 2025.

Anheuser Busch (BUD) had a current ratio of 0.72 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Anheuser Busch (BUD) had a debt-to-equity ratio of 0.75 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Anheuser Busch (BUD) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Anheuser Busch (BUD) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Anheuser Busch (BUD) has an earnings quality ratio of 1.76x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Anheuser Busch (BUD) scores 29 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top